Insider · CIK 0001008377

CONTE LISA A

Reports to the SEC for 1 company · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001008377

Forms 4 and 5

Insider transactions

40 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-11	JAGXJaguar Health, Inc.A Award	Director, See Remarks	AAward	+28.6K sh	—	—	29,258
2025-12-11	JAGXJaguar Health, Inc. · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+28.6K sh	—	—	28,592
2025-06-24	JAGXJaguar Health, Inc. · Convertible Promissory NoteD Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−9,000 sh	$50000.00	−$450M	0
2025-06-24	JAGXJaguar Health, Inc. · Convertible Promissory NoteA Award	Director, See Remarks	AAward	+9,462 sh	$50000.00	+$473M	9,462
2025-06-24	JAGXJaguar Health, Inc. · Warrant to Purchase Common StockA Award	Director, See Remarks	AAward	+18.3K sh	—	—	9,000
2025-05-17	JAGXJaguar Health, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+2 sh	—	—	666
2025-05-17	JAGXJaguar Health, Inc. · Restricted stock unitsM Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−2 sh	—	—	0
2025-03-31	JAGXJaguar Health, Inc. · Convertible Promissory NoteP Purchase	Director, See Remarks	PPurchase	+9,000 sh	$50000.00	+$450M	9,000
2025-03-31	JAGXJaguar Health, Inc. · Warrant to Purchase Common StockP Purchase	Director, See Remarks	PPurchase	+9,000 sh	—	—	9,000
2024-10-08	JAGXJaguar Health, Inc.A Award	Director, See Remarks	AAward	+16.5K sh	—	—	16,624
2024-10-08	JAGXJaguar Health, Inc. · Stock option (right to buy)A Award	Director, See Remarks	AAward	+132K sh	—	—	132,020
2024-05-17	JAGXJaguar Health, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+2,695 sh	—	—	7,295
2024-05-17	JAGXJaguar Health, Inc. · Restricted stock unitsM Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−2,695 sh	—	—	2,694
2024-04-05	JAGXJaguar Health, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+600 sh	—	—	4,600
2024-04-05	JAGXJaguar Health, Inc. · Restricted stock unitsA Award	Director, See Remarks	AAward	−600 sh	—	—	0
2023-08-14	JAGXJaguar Health, Inc.A Award	Director, See Remarks	AAward	+384K sh	—	—	387,605
2023-05-17	JAGXJaguar Health, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+2,694 sh	—	—	4,000
2023-05-17	JAGXJaguar Health, Inc. · Restricted stock unitsM Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−2,694 sh	—	—	5,389
2023-04-05	JAGXJaguar Health, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+600 sh	—	—	1,306
2023-04-05	JAGXJaguar Health, Inc. · Restricted stock unitsA Award	Director, See Remarks	AAward	+600 sh	—	—	600
2022-12-27	JAGXJaguar Health, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−143K sh	—	—	0
2022-04-05	JAGXJaguar Health, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+45K sh	—	—	53,003
2022-04-05	JAGXJaguar Health, Inc. · Restricted stock unitsA Award	Director, See Remarks	AAward	+45K sh	—	—	90,000
2022-03-28	JAGXJaguar Health, Inc. · Restricted stock unitsA Award	Director, See Remarks	AAward	+606K sh	—	—	606,280
2022-03-28	JAGXJaguar Health, Inc. · Restricted stock unitsA Award	Director, See Remarks	AAward	+25K sh	—	—	25,000
2021-09-13	JAGXJaguar Health, Inc.P Purchase	Director, See Remarks	PPurchase	+7,968 sh	$2.51	+$20K	8,003
2021-04-05	JAGXJaguar Health, Inc. · Stock option (right to buy)A Award	Director, See Remarks	AAward	+810K sh	—	—	810,000
2021-04-05	JAGXJaguar Health, Inc. · Restricted stock unitsA Award	Director, See Remarks	AAward	+405K sh	—	—	405,000
2020-03-20	JAGXJaguar Health, Inc. · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+238K sh	—	—	238,293
2019-07-24	JAGXJaguar Health, Inc. · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+1.04M sh	—	—	1,042,052
2019-06-07	JAGXJaguar Health, Inc. · Bridge Warrant to Purchase Common StockP Purchase	Director, See Remarks	PPurchase	+37.5K sh	—	—	37,500
2018-07-18	JAGXJaguar Health, Inc.P Purchase	Director, See Remarks	PPurchase	+1,500 sh	$1.11	+$1,668.6	7,500
2018-06-01	JAGXJaguar Health, Inc. · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+448K sh	—	—	447,935
2018-03-12	JAGXJaguar Health, Inc. · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+3.25M sh	—	—	3,247,242
2017-12-21	JAGXJaguar Health, Inc. · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+286K sh	—	—	285,807
2016-12-19	JAGXJaguar Health, Inc. · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+17K sh	—	—	16,998
2016-09-22	JAGXJaguar Health, Inc. · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+318K sh	—	—	318,000
2016-06-14	JAGXJaguar Health, Inc. · Stock option (right to buy)A Award	Director, See Remarks	AAward	+85.6K sh	—	—	85,616
2016-06-14	JAGXJaguar Health, Inc. · Stock option (right to buy)A Award	Director, See Remarks	AAward	+113K sh	—	—	113,212
2016-06-14	JAGXJaguar Health, Inc. · Stock option (right to buy)A Award	Director, See Remarks	AAward	+70K sh	—	—	69,970

Recent filings

Accepted (ET)
Jan 214
CONTE LISA A0001193125-26-018040
SEC(opens sec.gov)
Jun 264
CONTE LISA A0000950170-25-090433
SEC(opens sec.gov)
May 204
CONTE LISA A0000950170-25-075332
SEC(opens sec.gov)
Apr 24
CONTE LISA A0000950170-25-049806
SEC(opens sec.gov)
Oct 104
CONTE LISA A0000950170-24-114187
SEC(opens sec.gov)
May 214
CONTE LISA A0001104659-24-063892
SEC(opens sec.gov)
Apr 174
CONTE LISA A0001104659-24-048338
SEC(opens sec.gov)
Aug 144
CONTE LISA A0001104659-23-091447
SEC(opens sec.gov)
May 194
CONTE LISA A0001104659-23-062738
SEC(opens sec.gov)
Apr 204
CONTE LISA A0001104659-23-047871
SEC(opens sec.gov)

Companies

Jaguar Health, Inc.Director, See RemarksJAGX

Address

C/O JAGUAR HEALTH, INC. 200 PINE ST., STE 400

SAN FRANCISCO, CA, 94104